Mobile Menu

Search Results

Search results for: drug targets

It’s time to talk about epigenetic clocks

Ageing. Mother nature’s curse, but a plastic surgeon’s blessing. All humans age. But how we age and most importantly how […]

PRMT5: synthetic lethality target in pancreatic cancer cells

A team of researchers have used targeted CRISPR screening and have identified PRMT5 as a synthetic lethality combinatorial target with […]

TESLA unlocks a new generation of immunotherapy

The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement. Neoantigens Somatic alterations are […]

An up-close view of HIV

Researchers have recreated the first steps of infection by HIV in a test tube, providing an up-close access to the […]

Liquid biopsies for personalised cancer care

A team at The Institute of Cancer Research (ICR), London and The Royal Marsden NHS Foundation Trust have shown that […]

New hope for children and young people with cancer

September marks Childhood Cancer Awareness Month (CCAM) which takes place every year to increase awareness of cancer in children and […]

Let’s talk about colon cancer

The recent passing of actor and role model, Chadwick Boseman, from colon cancer has shocked the nation. This shock seems […]

MiR-93 as a potential novel target for breast cancer

A new study published in Cell Death and Disease has revealed the role of miR-93 in tumorigenesis and chemosensitivity. Breast […]

Study finds chemokine receptor inhibition can overcome immune hyperactivation in COVID-19 patients

A new single-cell analysis study of airway samples of COVID-19 patients has found that drugs targeting chemokine receptors may be […]

ICR and Cancer Research UK spinout launches library of anti-cancer compounds

Monte Rosa Therapeutics is a spin-out formed by Versant Ventures, The Institute of Cancer Research (ICR) and Cancer Research UK […]